# Clinical Trial of Protective Efficacy of Quadrivalent Recombinant Norovirus Vaccine (Pichia Pastoris)

> **NCT06524947** · PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.** · enrollment: 6600 (actual)

## Conditions studied

- Acute Gastroenteropathy Due to Norovirus

## Interventions

- **BIOLOGICAL:** quadrivalent recombinant norovirus vaccine (Pichia pastoris)
- **BIOLOGICAL:** quadrivalent recombinant norovirus vaccine (Pichia pastoris) placebo

## Key facts

- **NCT ID:** NCT06524947
- **Lead sponsor:** Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-07-27
- **Primary completion:** 2027-03-28
- **Final completion:** 2027-03-28
- **Target enrollment:** 6600 (ACTUAL)
- **Last updated:** 2025-01-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06524947

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06524947, "Clinical Trial of Protective Efficacy of Quadrivalent Recombinant Norovirus Vaccine (Pichia Pastoris)". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT06524947. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*